Patent classifications
A
A61
A61K
51/00
A61K51/02
A61K51/04
A61K51/08
A61K51/10
A61K51/1045
A61K51/1054
A61K51/1054
DLL3 BINDING MOLECULES AND USES THEREOF
20250051476
·
2025-02-13
·
Described herein are heavy chain antibodies that bind to DLL3 and immunoconjugates of DLL3 heavy chain antibodies useful for cancer therapy.
HUMANIZED ANTIBODY THAT BINDS TO HEG1 PROTEIN AND COMPLEX OF ANTIBODY AND RADIONUCLIDE
20250090700
·
2025-03-20
·
The present invention provides a humanized antibody that binds to a HEG1 protein and a complex of the antibody and a radionuclide. According to the present invention, there is a complex including an antibody, and a radionuclide, in which the antibody is a humanized antibody capable of binding a human HEG1 protein expressed on mesothelioma cells.
Polypeptide comprising a single-domain antibody variable region that binds delta-like ligand 3 (DLL3) and method of use thereof to make a radionuclide complex
12344675
·
2025-07-01
·
·
Described herein are heavy chain antibodies that bind to DLL3 and immunoconjugates of DLL3 heavy chain antibodies useful for cancer therapy.